{"text": "cost effectiveness of aducanumab and donanemab for early alzheimer disease in the us biib lly eisai rog rhhby bioab aduhelm cost effective at lt 3k y amp dona at 20k y"}
{"text": "stock biib realtime trend sell buy 40 53 sell 59 47 try now the best pivot point calculator tradingview stocks stockstowatch"}
{"text": "becoming clear that proteinopathies treatable through reduction of the pathological protein and nucleotide repeat disorders necessitate dna level correction to reduce repeat number ions biib"}
{"text": "it ll be tough for fda to take away tofersen from patients were some are showing signs of disease slowing many sod1 patients are taking tofersen now i would not close the door on this drug unless no improvement in ole ions biib"}
{"text": "biib below avg volume daily appearances since 2010 150 close 5 days later avg 1 08 sd 12 72 worst 80 31 best 50 59 10 days later avg 1 65 sd 17 30 worst 84 75 best 65 00 30 days later avg 0 21 sd 35 65 worst 88 61 best 147 11"}
{"text": "biogen ionis drop als candidate biib078 after failed early trial biib ions"}
